Literature DB >> 1585287

Liposomes for controlled delivery of drugs to the lung.

K M Taylor, J M Newton.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1585287      PMCID： PMC463682          DOI： 10.1136/thx.47.4.257

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  11 in total

1.  Acute effects of liposome aerosol inhalation on pulmonary function in healthy human volunteers.

Authors:  D A Thomas; M A Myers; B Wichert; H Schreier; R J Gonzalez-Rothi
Journal:  Chest       Date:  1991-05       Impact factor: 9.410

2.  Selective enhancement of pentamidine uptake in the lung by aerosolization and delivery in liposomes.

Authors:  R J Debs; R M Straubinger; E N Brunette; J M Lin; E J Lin; A B Montgomery; D S Friend; D P Papahadjopoulos
Journal:  Am Rev Respir Dis       Date:  1987-03

Review 3.  Metabolism and turnover of lung surfactant.

Authors:  J R Wright; J A Clements
Journal:  Am Rev Respir Dis       Date:  1987-08

4.  Pulmonary uptake of liposomal phosphatidylcholine upon intratracheal administration to rats.

Authors:  Y Morimoto; Y Adachi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1982-06       Impact factor: 1.645

5.  Organ-selective action of an antitumor drug: pharmacologic studies of liposome-encapsulated beta-cytosine arabinoside administered via the respiratory system of the rat.

Authors:  H N McCullough; R L Juliano
Journal:  J Natl Cancer Inst       Date:  1979-09       Impact factor: 13.506

6.  The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man.

Authors:  K M Taylor; G Taylor; I W Kellaway; J Stevens
Journal:  Pharm Res       Date:  1989-07       Impact factor: 4.200

7.  Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro.

Authors:  C Kirby; J Clarke; G Gregoriadis
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

8.  Liposomal pulmonary drug delivery. I. In vivo disposition of atropine base in solution and liposomal form following endotracheal instillation to the rabbit lung.

Authors:  D Meisner; J Pringle; M Mezei
Journal:  J Microencapsul       Date:  1989 Jul-Sep       Impact factor: 3.142

9.  Small particle aerosols of enviroxime-containing liposomes.

Authors:  B E Gilbert; H R Six; S Z Wilson; P R Wyde; V Knight
Journal:  Antiviral Res       Date:  1988-09       Impact factor: 5.970

10.  Ventilation enhances pulmonary alveolar clearance of radioactive dipalmitoyl phosphatidylcholine in liposomes.

Authors:  M J Oyarzún; J A Clements; A Baritussio
Journal:  Am Rev Respir Dis       Date:  1980-04
View more
  10 in total

Review 1.  Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.

Authors:  N R Labiris; M B Dolovich
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

Review 2.  Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.

Authors:  Paul Galvin; Damien Thompson; Katie B Ryan; Anna McCarthy; Anne C Moore; Conor S Burke; Maya Dyson; Brian D Maccraith; Yurii K Gun'ko; Michelle T Byrne; Yuri Volkov; Chris Keely; Enda Keehan; Michael Howe; Conor Duffy; Ronan MacLoughlin
Journal:  Cell Mol Life Sci       Date:  2011-10-21       Impact factor: 9.261

3.  Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability.

Authors:  Elke Kleemann; Thomas Schmehl; Tobias Gessler; Udo Bakowsky; Thomas Kissel; Werner Seeger
Journal:  Pharm Res       Date:  2006-12-27       Impact factor: 4.200

4.  Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema.

Authors:  I F Purcell; P A Corris
Journal:  Thorax       Date:  1995-12       Impact factor: 9.139

5.  Chapter 9 - Nanoliposomal dry powder formulations.

Authors:  Gaurang Patel; Mahavir Chougule; Mandip Singh; Ambikanandan Misra
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

6.  Plasmid-encoding vasostatin inhibited the growth and metastasis of human hepatocellular carcinoma cells.

Authors:  Xing-Chen Peng; Ming Wang; Xu-Xia Chen; Jing Liu; Gui-Hua Xiao; Hong-Li Liao
Journal:  Mol Cell Biochem       Date:  2014-07-06       Impact factor: 3.396

7.  Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension.

Authors:  Vivek Gupta; Nilesh Gupta; Imam H Shaik; Reza Mehvar; Ivan F McMurtry; Masahiko Oka; Eva Nozik-Grayck; Masanobu Komatsu; Fakhrul Ahsan
Journal:  J Control Release       Date:  2013-01-23       Impact factor: 9.776

Review 8.  Aerosol delivery systems for bronchial asthma.

Authors:  P L Ariyananda; J E Agnew; S W Clarke
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401

Review 9.  Dry Powder Inhalers: A Focus on Advancements in Novel Drug Delivery Systems.

Authors:  Piyush Mehta
Journal:  J Drug Deliv       Date:  2016-10-27

10.  Aerosol performance and long-term stability of surfactant-associated liposomal ciprofloxacin formulations with modified encapsulation and release properties.

Authors:  David Cipolla; Huiying Wu; Igor Gonda; Hak-Kim Chan
Journal:  AAPS PharmSciTech       Date:  2014-06-03       Impact factor: 3.246
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.